R. Babela

796 total citations · 1 hit paper
23 papers, 452 citations indexed

About

R. Babela is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Oncology. According to data from OpenAlex, R. Babela has authored 23 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Infectious Diseases and 4 papers in Oncology. Recurrent topics in R. Babela's work include Multiple Myeloma Research and Treatments (3 papers), Neutropenia and Cancer Infections (3 papers) and Antifungal resistance and susceptibility (2 papers). R. Babela is often cited by papers focused on Multiple Myeloma Research and Treatments (3 papers), Neutropenia and Cancer Infections (3 papers) and Antifungal resistance and susceptibility (2 papers). R. Babela collaborates with scholars based in Slovakia, United States and United Kingdom. R. Babela's co-authors include Trevor Richter, Zeba Khan, Dyfrig Hughes, Elizabeth Molsen, Sandra Nestler-Parr, V. Krčméry, F Mateička, Alex N. Sabo, Jurga Laurencikiene and Miloš Jeseňák and has published in prestigious journals such as SHILAP Revista de lepidopterología, BMC Health Services Research and Supportive Care in Cancer.

In The Last Decade

R. Babela

21 papers receiving 431 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rare Disease Terminology and Definitions—A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group

2015 345 citations Trevor Richter, Sandra Nestler-Parr et al. Value in Health profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Babela Slovakia	6	154	78	77	72	60	23	452
Anna G. C. Boef Netherlands	10	197 1.3×	101 1.3×	42 0.5×	112 1.6×	33 0.6×	15	566
Ahmed A. Suleiman Germany	16	85 0.6×	48 0.6×	36 0.5×	69 1.0×	28 0.5×	42	561
Charles Mathews United States	7	101 0.7×	52 0.7×	50 0.6×	30 0.4×	25 0.4×	10	306
Scott Bowen United States	9	170 1.1×	38 0.5×	29 0.4×	36 0.5×	22 0.4×	13	341
Katharina Büsch Sweden	10	166 1.1×	77 1.0×	30 0.4×	256 3.6×	35 0.6×	20	444
Kavitha Goyal United States	12	113 0.7×	41 0.5×	137 1.8×	114 1.6×	41 0.7×	22	1.0k
Ashok Kumar Jha India	10	60 0.4×	47 0.6×	66 0.9×	43 0.6×	15 0.3×	25	374
Viviana Lora Italy	17	72 0.5×	88 1.1×	22 0.3×	113 1.6×	15 0.3×	42	725
Neng Yu United States	19	95 0.6×	105 1.3×	32 0.4×	125 1.7×	16 0.3×	57	945

Countries citing papers authored by R. Babela

Since Specialization

Citations

This map shows the geographic impact of R. Babela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Babela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Babela more than expected).

Fields of papers citing papers by R. Babela

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Babela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Babela. The network helps show where R. Babela may publish in the future.

Co-authorship network of co-authors of R. Babela

This figure shows the co-authorship network connecting the top 25 collaborators of R. Babela. A scholar is included among the top collaborators of R. Babela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Babela. R. Babela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Babela, R., et al.. (2024). Prostate cancer in Slovakia: last decade overview. Bratislavské lekárske listy/Bratislava medical journal. 125(12). 835–843.

Babela, R., et al.. (2024). Epidemiology and comprehensive economic impact of atrial fibrillation and associated stroke in Slovakia. BMC Health Services Research. 24(1). 637–637. 1 indexed citations

Babela, R., et al.. (2021). Economic aspects of multiple myeloma: real costs associated with disease in the Slovak Republic. Neoplasma. 68(2). 454–464. 2 indexed citations

Babela, R., et al.. (2021). Cost-effectiveness of colorectal cancer screening in Slovakia. European Journal of Cancer Prevention. 31(5). 415–421. 10 indexed citations

Kralinský, K., et al.. (2020). Adaptive supportive ventilation in a child with coronavirus pneumonia and diabetes mellitus. SHILAP Revista de lepidopterología. 65(5). 66–72. 2 indexed citations

Babela, R., et al.. (2020). PMH18 Direct Costs Associated with Diagnosis of Depression within 3 YEARS (2016-2018) in Slovakia.. Value in Health. 23. S587–S587. 1 indexed citations

Kralinský, K., et al.. (2020). Protocol for the diagnosis, management and treatment of pediatric patients with COVID-19 according to the recommendations of the Slovakian Pediatric Society. SHILAP Revista de lepidopterología. 65(5). 93–99. 3 indexed citations

Babela, R., et al.. (2019). Selected Diagnoses in Hospitalized Patients in Palliative Care. 10(2). 40–42. 1 indexed citations

Krčméry, V., V. Hricak, M Mrázová, et al.. (2019). Etiology, Risk Factors and Outcome of 1003 Cases of Infective Endocarditis from a 33-year National Survey in the Slovak Republic: An increasing proportion of elderly patients.. PubMed. 39(8). 544–549. 5 indexed citations

10.

Babela, R., et al.. (2018). What are the Real Indirect Costs Associated with Multiple Myeloma: Model Patient Analysis From Slovak Republic. Value in Health. 21. S25–S25. 2 indexed citations

11.

Babela, R., et al.. (2018). Total Costs Distribution for Multiple Myeloma in Single Upper Middle Income Country: Is Cost Data Distribution Comparable with High Income Countries?. Value in Health. 21. S28–S28. 1 indexed citations

12.

Babela, R., et al.. (2018). Direct Costs Associated with Multiple Myeloma Model Patient in 2017 From Single EU Jurisdiction. Value in Health. 21. S27–S28. 1 indexed citations

13.

Babela, R., et al.. (2018). The effect of passive smoking on bacterial colonisation of the upper airways and selected laboratory parameters in children. Acta Otorhinolaryngologica Italica. 38(5). 431–438. 11 indexed citations

14.

Babela, R., et al.. (2018). Cost-effectiveness of the SQ HDM SLIT-tablet for the treatment of allergic asthma in three Eastern European Countries. European Annals of Allergy and Clinical Immunology. 51(2). 68–68. 3 indexed citations

15.

Babela, R., et al.. (2017). Decision and cost analysis of empirical antibiotic therapy of acute sinusitis in the era of increasing antimicrobial resistance: do we have an additional tool for antibiotic policy decisions?. PubMed. 38(Suppl1). 9–26. 1 indexed citations

16.

Richter, Trevor, Sandra Nestler-Parr, R. Babela, et al.. (2015). Rare Disease Terminology and Definitions—A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group. Value in Health. 18(6). 906–914. 345 indexed citations breakdown →

17.

Babela, R., et al.. (2005). Social Marketing as a Tool to Improve Behavioral Health Services for Underserved Populations in Transition Countries. The Health Care Manager. 24(1). 12–20. 1 indexed citations

18.

Krčméry, V., J. Trupl, A. Kunová, et al.. (2001). Antibiotic Use and Development of Resistance in Blood Culture Isolates: 8 Years of Experience from a Cancer Referral Center. Journal of Chemotherapy. 13(2). 133–142. 4 indexed citations

19.

Babela, R., et al.. (2001). Nosocomial fungemia due to amphotericin B-resistant Candida spp. in three pediatric patients after previous neurosurgery for brain tumors. Journal of Infection and Chemotherapy. 7(1). 45–48. 29 indexed citations

20.

Kaiserová, E, R. Babela, F Mateička, et al.. (2000). Prospective study on fungemia in children with cancer: analysis of 35 cases and comparison with 130 fungemias in adults. Supportive Care in Cancer. 8(5). 427–430. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact